Symptomatic obstructive hypertrophic cardiomyopathy
Clinical trials for Symptomatic obstructive hypertrophic cardiomyopathy explained in plain language.
Never miss a new study
Get alerted when new Symptomatic obstructive hypertrophic cardiomyopathy trials appear
Sign up with your email to follow new studies for Symptomatic obstructive hypertrophic cardiomyopathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to help kids with stiff heart muscle breathe easier
Disease control OngoingThis study tests a medicine called aficamten in children aged 12 to 18 with a heart condition that makes it hard for blood to pump out. The goal is to see if the drug can reduce pressure inside the heart and improve symptoms like shortness of breath. About 55 participants will re…
Matched conditions: SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase 2/3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New heart drug mavacamten tested in indian patients
Disease control OngoingThis study tests the drug mavacamten in 50 adults in India who have a condition where the heart muscle is too thick and blocks blood flow, causing symptoms like shortness of breath and chest pain. The goal is to see if the drug is safe and works well. Participants will take the d…
Matched conditions: SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase 4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC